On Jun. 13, 2024, BioMADE announced an investment in a state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support of up to $100 million from Governor Tim Walz and the Minnesota Legislature in the 2023 legislative session. The biomanufacturing infrastructure investments in Minnesota were the first in a national network of critically needed pilot-scale biomanufacturing innovation facilities with the goal of transforming American manufacturing for the 21st century.

Bioindustrial manufacturing uses biology to convert agricultural feedstocks and waste streams to high-value chemicals, materials, and products that Americans use every day. Cement, fire-resistant materials, durable fibers, bioplastics, food products, and more can all be created through bioindustrial manufacturing.

The bipartisan support from state of Minnesota builds on federal investment and domestic biomanufacturing priorities established by Congress and the Biden administration. Congress included an initial investment of $300 million through the FY23 Consolidated Appropriations Act to support the first phase of a network of pilot-scale bioindustrial manufacturing infrastructure around the country. Starting with this Minnesota site, BioMADE and its partners will establish the U.S. as a leader in the burgeoning bioeconomy while also strengthening American competitiveness and retaining American research and development efforts. Additionally, in September 2022, President Biden signed Executive Order 14081, which was issued to provide a whole-of-government approach for building a sustainable, safe, and secure American bioeconomy.

Bioindustrial manufacturing uses biology to convert agricultural feedstocks and waste streams to high-value chemicals, materials, and products that Americans use every day. Cement, fire-resistant materials, durable fibers, bioplastics, food products, and more can all be created through bioindustrial manufacturing.

The bipartisan support from state of Minnesota builds on federal investment and domestic biomanufacturing priorities established by Congress and the Biden administration. Congress included an initial investment of $300 million through the FY23 Consolidated Appropriations Act to support the first phase of a network of pilot-scale bioindustrial manufacturing infrastructure around the country. Starting with this Minnesota site, BioMADE and its partners will establish the U.S. as a leader in the burgeoning bioeconomy while also strengthening American competitiveness and retaining American research and development efforts. Additionally, in September 2022, President Biden signed Executive Order 14081, which was issued to provide a whole-of-government approach for building a sustainable, safe, and secure American bioeconomy.

BioMADE is securing America’s future through biomanufacturing innovation, education, and collaboration. Bioindustrial manufacturing uses biology to convert agricultural feedstocks and waste streams to high-value chemicals, materials, and products.

By harnessing the power of biology, BioMADE and its 200+ member organizations are creating more robust and resilient supply chains, making the U.S. more self-sufficient, re-shoring manufacturing jobs, and producing more environmentally sustainable products without relying on traditional petroleum sources. BioMADE is also building a globally competitive STEM workforce to ensure American workers are prepared and ready to fill new jobs within this rapidly growing industry. BioMADE is a Manufacturing Innovation Institute catalyzed by the U.S. Department of Defense in 2021.